Publicacións en colaboración con investigadores/as de Pfizer (United States) (17)

2024

  1. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients

    Clinical and Translational Oncology

  2. RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy, Vol. 13, Núm. 9, pp. 1983-1999

  3. Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy, Vol. 13, Núm. 11, pp. 2395-2413

  4. Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey

    Journal of Headache and Pain, Vol. 25, Núm. 1

2023

  1. Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial

    Clinical Infectious Diseases, Vol. 77, Núm. 2, pp. 312-320

2020

  1. The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

    Contemporary Clinical Trials, Vol. 98

2019

  1. Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion

    OncoImmunology, Vol. 8, Núm. 11

2018

  1. A computational framework for complex disease stratification from multiple large-scale datasets

    BMC Systems Biology, Vol. 12, Núm. 1

2015

  1. Impacto del consumo de tabaco sobre la mortalidad en España en el año 2012

    Medicina Clinica, Vol. 145, Núm. 12, pp. 520-525

2013

  1. A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones

    Tetrahedron Letters, Vol. 54, Núm. 27, pp. 3493-3495

2008

  1. Burden of illness of bilateral neovascular age-related macular degeneration in Spain

    Current Medical Research and Opinion

2007

  1. Effects of Atorvastatin on Vitamin D Levels in Patients With Acute Ischemic Heart Disease

    American Journal of Cardiology, Vol. 99, Núm. 7, pp. 903-905

2006

  1. Effects of statins on bone markers bone mineral density and fractures. Possible role in osteoporosis treatment

    Current Pharmaceutical Analysis, Vol. 2, Núm. 2, pp. 161-168

2005

  1. Effect of atorvastatin to RANKL/OPG system in patients with acute coronary syndrome

    Journal of Applied Research, Vol. 5, Núm. 4, pp. 569-574

2003

  1. Bone mass and bone modelling markers in hypertensive postmenopausal women

    Journal of Human Hypertension, Vol. 17, Núm. 2, pp. 107-110

  2. Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: Relationship with angiotensin converting enzyme polymorphisms

    American Journal of Hypertension, Vol. 16, Núm. 6, pp. 453-459

  3. Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women

    American Journal of Hypertension, Vol. 16, Núm. 3, pp. 233-235